Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency - PubMed (original) (raw)

Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency

Jenny Hansson et al. Cell Rep. 2012.

Abstract

Generation of induced pluripotent stem cells (iPSCs) is a process whose mechanistic underpinnings are only beginning to emerge. Here, we applied in-depth quantitative proteomics to monitor proteome changes during the course of reprogramming of fibroblasts to iPSCs. We uncover a two-step resetting of the proteome during the first and last 3 days of reprogramming, with multiple functionally related proteins changing in expression in a highly coordinated fashion. This comprised several biological processes, including changes in the stoichiometry of electron transport-chain complexes, repressed vesicle-mediated transport during the intermediate stage, and an EMT-like process in the late phase. In addition, we demonstrate that the nucleoporin Nup210 is essential for reprogramming by its permitting of rapid cellular proliferation and subsequent progression through MET. Along with the identification of proteins expressed in a stage-specific manner, this study provides a rich resource toward an enhanced mechanistic understanding of cellular reprogramming.

Copyright © 2012 The Authors. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Figures

Figure 1

Figure 1. (A) Experimental design of the study

Reprogramming was induced by expressing Oct4, Klf4, Sox2 and c-Myc. Cells were isolated at 3-day intervals by FACS sorting based on Thy1, SSEA-1 and GFP-Oct4 expression, followed by a quantitative proteomic analysis by pairwise comparison of two consecutive time-points. See also Fig. S1A. (B–F) Expression of transcription factors during reprogramming. (B) Expression profiles of the reprogramming factors. The average log2 expression change to day 0 +/− SEM for the transcription factors that were used to initiate reprogramming. C-Myc was not covered by the data, possibly because it is refractory to tryptic digestion. (C) Expression patterns of proteins in the core regulatory circuit associated with pluripotency. (D) Network of induced transcription factors that interact with the reprogramming factors. Increased expression early, transient or late is depicted in gray-scale. (E–F) Number of differentially expressed proteins that are targets of Oct4, Sox2, Klf4 or c-Myc (E) and other TFs (F). See also Figure S1.

Figure 2

Figure 2. Proteome dynamics during reprogramming. (A) Heat map showing expression changes along reprogramming

The row-clustered heatmap represents standardized average protein log2 ratios for all 5601 proteins quantified at all time-point comparisons, in both replicates. Note that most changes occur early and late. (B) Strong expression changes early and late show opposing direction. Log2 ratios of proteins with strong expression change both early and late during reprogramming (fold change >2 and ratio count ≥2 in both replicates from day 0 to day 3 and day 12 to day 15) are shown, together with the Pearson correlation coefficient. (C) Clusters of the protein dynamics along reprogramming. For the 5601 proteins quantified at all time-points (in both replicates), the ratio relative to day 0 was standardized and proteins were subjected to unsupervised clustering. An upper and lower ratio limit of log2(0.5) and log2(−0.5) was used for inclusion into a cluster. ‘n’ indicates the number of proteins within each cluster. Membership value represents how well the protein profile fit the average cluster profile. (D–E) Representative overrepresented biological processes and cellular components of the clusters. Each cluster from C was tested for overrepresented GO Biological Processes (D) and GO Cellular Components (E) compared to unregulated proteins. See also Figure S2.

Figure 3

Figure 3. (A) Overrepresented network processes for protein expression changes early and late

Proteins with expression change (fold change >1.4 (|0.5| on log2-scale)) both early and late during reprogramming, were tested for overrepresented network processes. Displayed network processes were found overrepresented (p<0.01) both early and late. Note that no process was overrepresented for proteins whose expression decreased both from day 0 to day 3 and day 12 to iPS. (B) Temporal expression profiles of proteins related to EMT and MET. (C) Temporal expression profiles of proteins related to cytoskeletal organization and ECM proteins. See also Figure S3.

Figure 4

Figure 4. Proteins within complexes or with related function showing exceptionally similar dynamics along reprogramming

The significance of expression profile similarities within groups of interest was assessed using the R package proteinProfiles. (A) Examples of protein complexes or protein families for which the proteins show similar dynamics with statistical significance (all examples have p<0.015). (B) Clustering of mitochondrial and cytoplasmic ribosomal proteins. Similarities in expression profiles showed statistical significance within all four ribosomal subunits (28S and 39S (mitochondrial) and 40S and 60S (cytoplasmic)) (maximal p-value was 0.0005). The proteins of all four subunits were grouped by unsupervised clustering based on expression changes. Mitochondrial and cytoplasmic are indicated in green and purple, respectively.

Figure 5

Figure 5. (A) Functionally related proteins with opposing expression profile along reprogramming

Curves show mean+/− SEM of log2 expression change relative to day 0. (B–C) Principal component analysis reveals candidate proteins contributing particularly to a specific time-point. A PCA was applied to the approximated abundances (iBAQ) of each protein at each time-point. Proteins with probable high contribution to each time-point are highlighted in the biplot (B) and their temporal expression profiles shown in (C), with the same color-coding as in (B). (D) Proteins with a stage-specific expression pattern. Temporal expression profiles for examples of proteins with strong change (>fold 1.5) in at least one of the intermediate time-point comparisons, and only low change (<1.3-fold) or absence day 0 to day 3. Curves show mean +−/SEM of log2 expression change to day 0.

Figure 6

Figure 6. Nup210 is required for reprogramming. (A) Protein xxpression profile of nucleoporins

Curves show mean+/− SEM of log2 expression change relative to day 0. (B–E) Nup210 was depleted (using shRNA) in secondary MEF cells during reprogramming to iPS cells. (B) Number of colonies (mean+/− SD) in controls and Nup210 knocked-down cells are shown, for two independent Nup210 shRNAs. (C) While many Oct4-EGFP colonies developed in the controls, Nup210-knock down cells showed expression of Fibronectin and the mesenchymal marker Snail after 15 days of reprogramming. Upper panel shows iPS colony formation for control cells, and lower panel the Nup210 knock-down cells and their expression of Fibronectin and Snail at day 15 after induction of reprogramming. Scale bar represents 100 μm. For Snail expression, the border of the nucleus (defined by Hoechst staining, see Figure S4) is shown in blue, demonstrating that virtually all cells retain a mesenchymal phenotype. (D) Relative gene expression (mean+/− SD) in control and Nup210 knocked-down cells 15 days after reprogramming. (E) Growth curve for control and Nup210-knock down MEFs.

Figure 7

Figure 7. Model of highly coordinated proteome dynamics during reprogramming

Protein upregulation and downregulation is shown in red and blue, respectively, where color intensity reflects the degree of regulation. Examples are given of individual proteins that are expressed or repressed in a stage-specific manner.

Similar articles

Cited by

References

    1. Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S, Auersperg N. Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol. 2006;290:C1532–1542. - PubMed
    1. Begum A, Kim Y, Lin Q, Yun Z. DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo. Cancer Lett. 2012;318:26–33. - PMC - PubMed
    1. Boekema EJ, Braun HP. Supramolecular structure of the mitochondrial oxidative phosphorylation system. J Biol Chem. 2007;282:1–4. - PubMed
    1. Boersema PJ, Raijmakers R, Lemeer S, Mohammed S, Heck AJ. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat Protoc. 2009;4:484–494. - PubMed
    1. Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell. 2008;2:151–159. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources